Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Tasnime Issoufaly (Paris, France), Tasnime Issoufaly, Raphaël Lhote, Louis-Jean Couderc, Leila Zemoura, Colas Tcherakian. Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 3685

Member's Comments

No comment yet.

Related content which might interest you: Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007 ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 444s Year: 2002 Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009 Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy Source: Eur Respir J 2015; 46: 554-557 Year: 2015 Are non-cystic fibrosis bronchiectasis a result of primary antibody deficiency? Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Specific IgG antibodies in chronic hypersensitivity pneumonitis Source: International Congress 2015 – IIPs: orphan Year: 2015 Anti-neutrophil cytoplasmic antibodies and immune complexes vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=91 Year: 2005 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies. Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease: CT findings in 149 patients Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis Source: Eur Respir J 2011; 37: 1503-1513 Year: 2011 Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002 Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016